Gross Profit On Sales تغییر دادن تاریخ
AbbVie USD 9.56B 95M 2023-09
Acadia Pharmaceuticals USD 213.15M 16.07M 2023-12
ALKERMES USD 319.43M 234.71M 2023-09
Amgen USD 5.08B 14M 2023-12
Bayer EUR 5.53B 796M 2023-09
Biogen USD 1.77B 102.7M 2023-12
BioMarin Pharmaceutical USD 510.73M 54.14M 2023-12
Bluebird Bio USD 1.44M 4.11M 2023-09
Bristol-Myers Squibb USD 8.77B 294M 2023-12
Eli Lilly USD 7.57B 73.1M 2023-12
Esperion Therapeutics USD 20.59M 1.59M 2023-09
Gilead Sciences USD 5.5B 18M 2023-12
Incyte USD 949.29M 84.66M 2023-12
Intra Cellular Therapies USD 121.4M 4.35M 2023-12
Marinus Pharmaceuticals USD 6.88M 1.19M 2023-09
Merck USD 11.29B 441M 2023-12
Moderna USD 1.88B 2.29B 2023-12
Neurocrine Biosciences USD 487.6M 46.4M 2023-09
Pfizer USD 7.58B 3.26B 2023-12
PTC Therapeutics USD 277.94M 90.85M 2023-12
Regeneron Pharmaceuticals USD 2.92B 9M 2023-12
Sarepta Therapeutics USD 294.79M 67.68M 2023-09
Teva Pharmaceutical Industries USD 1.9B 20M 2023-09
Ultragenyx Pharmaceutical USD 115.34M 28.28M 2023-12
United Therapeutics USD 543.7M 4.4M 2023-12
Vertex Pharmaceuticals USD 2.16B 19.8M 2023-09



Biogen سود ناخالص در فروش - ارزش های فعلی، داده های تاریخی، پیش بینی، آمار، نمودار و تقویم اقتصادی - Mar 2024.